CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia. (2022)
Attributed to:
Generating platelets in vitro for the clinic: optimisation and added clinical efficacy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood.2021013113
PubMed Identifier: 35051265
Publication URI: http://europepmc.org/abstract/MED/35051265
Type: Journal Article/Review
Volume: 139
Parent Publication: Blood
Issue: 14
ISSN: 0006-4971